COPS5 and atherosclerosis: Expanding on this observation, we explored the impact of myeloid-specific Csn5-deficiency in experimental atherosclerosis in vivo, using high fat diet-fed atherogenic Apoe−/− mice as a preclinical model of atherosclerosis.